Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Recognized Consensus Standards
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search Back To Search Results
Part B: Supplementary Information Sheet (SIS)
FR Recognition List Number 041 Date of Entry 04/04/2016 
FR Recognition Number 7-260
Standard
CLSI MM03-3rd Edition (Replaces MM03-A2) Molecular Diagnostic Methods for Infectious Diseases; Approved Guideline
Scope/Abstract
This document provides recommendations for cytology laboratories to use in developing preexamination, examination, and postexamination processes and procedures for nongynecological cytology specimen management.
Extent of Recognition
Complete standard
Public Law, CFR Citation(s) and Procode(s)*
Regulation Number Device Name Device Class Product Code
§866.3120 Dna Probe, Nucleic Acid Amplification, Chlamydia Class 1 MKZ
§866.3120 Dna-Reagents, Chlamydia Class 1 LSK
§866.3370 Dna-Reagents, Mycobacterium Spp. Class 1 LQF
§866.3390 Dna-Reagents, Neisseria Class 2 LSL
Relevant FDA Guidance and/or Supportive Publications*
Draft Guidance for Industry and FDA Staff Nucleic Acid Based In Vitro Diagnostic Devices for Detection of Microbial Pathogens, Issued December 2005.

FDA Technical Contact
 Li Li
  FDA/OC/CDRH/OPEQ/OIDRH/DMD/VIR1/
  301-796-6200
  li.li2@fda.hhs.gov
Standards Development Organization
CLSI Clinical Laboratory Standards Institute https://clsi.org/
FDA Specialty Task Group (STG)
InVitro Diagnostics
*These are provided as examples and others may be applicable.
-
-